Awards & Publications

Chairman and Professor, and Medical Director of the Department of Pathology and Laboratory
Medicine at Cedars-Sinai Medical Center (2006-current). Transformed a community-based practice with
academic interest into a nationally and internationally recognized academic department. Developed
Translational Pathology and Experimental Pathology Sections and Institutional Biorepository and
Morphology Core at the Medical Center.
Professor of Pathology & Vice Chair of Department of Pathology and Laboratory Medicine at UCLA,
David Geffen School of Medicine (2007-current).
Editor-in-Chief of the 8th edition of the American Joint Committee on Cancer (AJCC) staging manual
coordinating the activities of over 500 national and international authorities in cancer to outline the next
edition of cancer staging (staging manual to be published in 2016. The AJCC staging system is widely
used in clinical decision-making of all patients with cancer, to define clinical and translational research
and healthcare policy in cancer.
Director of Surgical Pathology, Professor (tenured, 2003) Pathology & Lab Medicine, Urology and
Hematology Oncology, Emory University Hospital (1998-2006). Also assisted in coordination of surgical
pathology services for 5 hospitals within the Emory System.
Associate Director, Winship Cancer Institute, Cancer Pathogenomics, Emory University School of
Medicine (2003-2006).
National and international consultant in tumors of the genitourinary tract, including prostate, urinary
bladder, kidney, and testis.
Scientific interests are in the discovery and validation of biomarkers in urologic malignancies for clinical
personalized medicine.
Involved with the first major descriptions of entities in genitourinary pathology including
lymphoepithelioma-like carcinoma of the bladder, micropapillary carcinoma of the bladder, acquired
cystic disease associated renal cell carcinoma, clear cell-papillary renal cell carcinoma, thyroid-like
carcinoma of the kidney and tubulocystic carcinoma of the kidney.
Internationally recognized expert and educator in genitourinary pathology having co-authored the
current World Health Organization (WHO) classification systems for urothelial tumors and renal
neoplasms; currently involved in developing the 2015 WHO classification systems for tumors of the
prostate, bladder, kidney and testis.
Co-authored and co-editor 10 books, including two Armed Forces Institute of Pathology (AFIP)
fascicles, two major texts in urologic pathology and a monograph on Gleason grading of prostate
cancer.
Authored approximately 300 publications and 40 book chapters.
Participated in federally funded research (NIH, DOD) as principal investigator, collaborator or
consultant.
Given over 313 lectureships - grand rounds, lectures and workshops in 20 countries.
Member of the faculty for national courses for the American Urology Association (AUA), United States
and Canadian Academy of Pathologists (USCAP) (since 1995) and CAP since 2003.
Editor-in-Chief of Advances in Anatomic Pathology since the year 2000.
Chair of the Cancer Committee of the College of American Pathologists (CAP). Led the cause for
standardized pathologic reporting of all cancer in the United States and the committees' work resulted
in one of the important standards of the American College of Surgeons, Commission on Cancer center
accreditation program in the United States and the CAP's laboratory accreditation program.
Awarded the prestigious Young Investigator Award of the Arthur Purdy Stout Society of Surgical
Pathologists in 2001.
Recipient of very prestigious awards through the College of American Pathologists including the 2010
CAP Foundation Lansky Award and the 2010 CAP Distinguished Service Award.
As Medical Director, led the Department of Pathology & Laboratory Medicine at Cedars-Sinai selection
as "Lab of the Year 2014" by Medical Laboratory Observer (MLO), a national networking magazine
whose primary audience is laboratory directors, medical technologist leaders and hospital
administrators.